loading...| Preferred Name |
Telaprevir |
|
| Synonyms |
|
|
| Definitions |
An orally available peptidomimetic small molecule with activity against hepatitis C virus (HCV). Telaprivir is a selective protease inhibitor that targets the viral HCV NS3-4A serine protease and disrupts processing of viral proteins and formation of a viral replication complex. |
|
| ID |
http://purl.obolibrary.org/obo/NCIT_C81603 |
|
| Accepted_Therapeutic_Use_For |
Chronic Hepatitis C |
|
| CAS_Registry |
402957-28-2 |
|
| Chemical_Formula |
C36H53N7O6 |
|
| code |
C81603 |
|
| Contributing_Source |
CTRP FDA |
|
| definition |
An orally available peptidomimetic small molecule with activity against hepatitis C virus (HCV). Telaprivir is a selective protease inhibitor that targets the viral HCV NS3-4A serine protease and disrupts processing of viral proteins and formation of a viral replication complex. |
|
| Display_Name |
Telaprevir |
|
| FDA_UNII_Code |
655M5O3W0U |
|
| in_subset |
http://purl.obolibrary.org/obo/NCIT_C63923 http://purl.obolibrary.org/obo/NCIT_C176424 |
|
| label |
Telaprevir |
|
| Legacy Concept Name |
Telaprevir |
|
| NCI_Drug_Dictionary_ID |
748913 |
|
| PDQ_Closed_Trial_Search_ID |
748913 |
|
| PDQ_Open_Trial_Search_ID |
748913 |
|
| Preferred_Name |
Telaprevir |
|
| prefixIRI |
NCIT:C81603 |
|
| prefLabel |
Telaprevir |
|
| Semantic_Type |
Pharmacologic Substance |
|
| UMLS_CUI |
C1876229 |
|
| subClassOf |